169 related articles for article (PubMed ID: 8787245)
41. Cocaine use and abuse triggering sporadic young-onset amyotrophic lateral sclerosis.
Argyriou AA; Karanasios P; Makridou A; Vlachou M; Giannakopoulou F; Makris N
Neurodegener Dis; 2011; 8(3):146-8. PubMed ID: 20714119
[TBL] [Abstract][Full Text] [Related]
42. Amyotrophic lateral sclerosis: Part 2. Etiopathogenesis.
Tandan R; Bradley WG
Ann Neurol; 1985 Oct; 18(4):419-31. PubMed ID: 2416263
[TBL] [Abstract][Full Text] [Related]
43. Overview of the pathogenesis and therapy of amyotrophic lateral sclerosis.
Serratrice GT; Munsat TL
Adv Neurol; 1995; 68():1-5. PubMed ID: 8787219
[No Abstract] [Full Text] [Related]
44. EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis.
Rosenblum LT; Trotti D
Adv Neurobiol; 2017; 16():117-136. PubMed ID: 28828608
[TBL] [Abstract][Full Text] [Related]
45. The glutamate hypothesis in ALS: pathophysiology and drug development.
Blasco H; Mavel S; Corcia P; Gordon PH
Curr Med Chem; 2014; 21(31):3551-75. PubMed ID: 25245510
[TBL] [Abstract][Full Text] [Related]
46. The pathogenesis of ALS: implications for treatment strategies.
Silani V; Braga M; Cardin V; Scarlato G
Neurol Neurochir Pol; 2001; 35(1 Suppl):25-39. PubMed ID: 11732278
[TBL] [Abstract][Full Text] [Related]
47. The possible role of a secondary pathogenetic factor in amyotrophic lateral sclerosis.
Pinelli P; Pisano F; Miscio G
Adv Neurol; 1995; 68():29-40. PubMed ID: 8787240
[No Abstract] [Full Text] [Related]
48. Amyotrophic lateral sclerosis. A multifactorial disease.
Eisen AA
Adv Neurol; 1995; 68():121-34. PubMed ID: 8787221
[No Abstract] [Full Text] [Related]
49. Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.
Festoff BW; Suo Z; Citron BA
CNS Drugs; 2003; 17(10):699-717. PubMed ID: 12873154
[TBL] [Abstract][Full Text] [Related]
50. Does excitotoxic cell death of motor neurons in ALS arise from glutamate transporter and glutamate receptor abnormalities?
Rattray M; Bendotti C
Exp Neurol; 2006 Sep; 201(1):15-23. PubMed ID: 16806177
[No Abstract] [Full Text] [Related]
51. Sporadic amyotrophic lateral sclerosis: new hypothesis regarding its etiology and pathogenesis suggests that astrocytes might be the primary target hosting a still unknown external agent.
Sica RE; Nicola AF; González Deniselle MC; Rodriguez G; Monachelli GM; Peralta LM; Bettini M
Arq Neuropsiquiatr; 2011 Aug; 69(4):699-706. PubMed ID: 21877044
[TBL] [Abstract][Full Text] [Related]
52. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis.
Foran E; Trotti D
Antioxid Redox Signal; 2009 Jul; 11(7):1587-602. PubMed ID: 19413484
[TBL] [Abstract][Full Text] [Related]
53. Pathogenesis and therapy of amyotrophic lateral sclerosis. Introduction.
Serratrice GT; Munsat TL
Adv Neurol; 1995; 68():xix-xx. PubMed ID: 8787218
[No Abstract] [Full Text] [Related]
54. [Amyotrophic lateral sclerosis].
Martí-Fàbregas J; Pradas J
Neurologia; 1996 Mar; 11(3):99-108. PubMed ID: 8695148
[TBL] [Abstract][Full Text] [Related]
55. Excitotoxicity hypothesis.
Rothstein JD
Neurology; 1996 Oct; 47(4 Suppl 2):S19-25; discussion S26. PubMed ID: 8858047
[No Abstract] [Full Text] [Related]
56. Are human neurodegenerative disorders linked to environmental chemicals with excitotoxic properties?
Spencer PS; Ludolph AC; Kisby GE
Ann N Y Acad Sci; 1992 May; 648():154-60. PubMed ID: 1322079
[TBL] [Abstract][Full Text] [Related]
57. The Serotonergic System and Amyotrophic Lateral Sclerosis: A Review of Current Evidence.
Yang L; Cheng Y; Zhu Y; Cui L; Li X
Cell Mol Neurobiol; 2023 Aug; 43(6):2387-2414. PubMed ID: 36729314
[TBL] [Abstract][Full Text] [Related]
58. Brain glutamate deficiency in amyotrophic lateral sclerosis.
Perry TL; Hansen S; Jones K
Neurology; 1987 Dec; 37(12):1845-8. PubMed ID: 2891083
[TBL] [Abstract][Full Text] [Related]
59. Amyotrophic lateral sclerosis: the involvement of intracellular Ca2+ and protein kinase C.
Krieger C; Lanius RA; Pelech SL; Shaw CA
Trends Pharmacol Sci; 1996 Mar; 17(3):114-20. PubMed ID: 8936348
[TBL] [Abstract][Full Text] [Related]
60. Amyotrophic lateral sclerosis and glutamate--too much of a good thing?
Choi DW
N Engl J Med; 1992 May; 326(22):1493-5. PubMed ID: 1349425
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
